HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Battle Of Anti-Acne Devices Heats Up; Prescription Claro Is First To Use IPL

This article was originally published in The Rose Sheet

Executive Summary

The number of devices touted as supplements or outright replacements for traditional acne treatments - based on their fast results and relative lack of adverse side effects - is on the rise

You may also be interested in...



Two Acne-Zapping Smartphone Apps Shut Down; FTC On Lookout For Others

Smartphones can do a lot of things, but curing acne is likely not one of them.

Two Acne-Zapping Smartphone Apps Shut Down; FTC On Lookout For Others

Smartphones can do a lot of things, but curing acne is likely not one of them.

Dermaray Light-Based Devices Treat Acne, Aging At Home

Australian firm TCG Industrial has introduced a pair of hand-held, battery-operated devices - for administering ultraviolet and laser phototherapy - that it says can be used at home to treat skin complaints ranging from psoriasis to acne to signs of aging

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS015956

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel